Home Pharmaceuticals LAMEA Lidocaine Market Size, Growth to 2022-2030

LAMEA Lidocaine Market

Select Regional / Country Report

LAMEA Lidocaine Market Size, Share & Trends Analysis Report By formulation (Injections, Creams, Ointments, Gel), By Application (Dentistry, Cardiac Arrhythmia, Epilepsy, Cosmetic Surgery, General Surgery), By Distribution Channel (Hospitals Outlets, Retail Pharmacies) and By Country(Brazil, Mexico, Argentina, Chile, Colombia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of LAMEA) Forecasts, 2022-2030

Report Code: SRPH3137DR
Study Period 2018-2030 CAGR 5.15%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD XX Billion
Forecast Year 2030 Forecast Year Market Size USD 96.28 Million
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The LAMEA Lidocaine Market size is expected to reach a valuation of USD 96.28 million by 2030, growing at a rate of 5.15 % CAGR during the forecast period (2022–2030) and for Middle East and Africa Lidocaine Market size is expected to reach a valuation of USD 273.77 million by 2030, increasing at a rate of 5.30 % CAGR during the forecast period (2022–2030).

Lidocaine is a xylidine-derived aminoethyl amide that is used as a local anaesthetic. Other anaesthetics, such as procaine, have a longer-lasting, broader, and faster action. The number of surgical treatments, such as dental procedures, aesthetic surgery, and plastic surgeries, conducted around the world is predicted to rise. The growth in chronic and acute pain disorders around the world, as well as the numerous benefits connected with lidocaine hydrochloride, are some of the primary reasons driving market expansion. Following an increase in the number of surgical procedures, a noticeable trend in the market is a considerable increase in the need for postoperative pain management treatments. Lidocaine hydrochloride demand is likely to continue to rise as a result of this trend. Over 75% of persons who have surgery experience acute postoperative pain, which is usually moderate to severe in severity, according to the study "Postoperative Pain Control," which helps them grow faster.

Lidocaine's use as an anti-itching and pain reliever for bug bites, small wounds, burns, skin scrapes, and eczema has increased demand, moving the market ahead. Latin America's impact factors are favourable for the development of the region. The number of procedures conducted globally, including in some Middle East and African regions, has increased dramatically over the last few years. A critical trend is a high need for postoperative pain treatment solutions following an increasing number of procedures. This trend is projected to have a favourable impact on the lidocaine ointment market. This trend is predicted to have a beneficial impact on the demand for lidocaine ointment.

Market Dynamics

Market Driving Factors

  • Rising Dental Health Demand Will Boost the Lidocaine Market: Tobacco usage, excessive sugar consumption, and binge drinking are all factors that contribute to oral diseases. According to the World Health Organization, oral problems affect a large portion of the people in the region. Furthermore, primary tooth decay affects about 530 million children, whereas permanent tooth decay affects 2.3 billion people. The majority of oral health difficulties are caused by periodontal disorders, Oro-dental trauma, oral signs of HIV, and periodontal illnesses. In many LAMEA countries, oral disorders are a major source of discomfort, agony, deformity, and even death. As the number of people who require dental treatment grows, so will the demand for lidocaine.
  • Increasing Chronic pain-related disorders: Chronic pain can endure for months or even years, and it can affect any region of the body. It hinders daily activities and might lead to despair and anxiety. Chronic pain can make it difficult to go about your everyday activities, such as working, socialising, and caring for yourself or others. The prevalence of chronic pain has increased in numerous LAMEA nations, including Saudi Arabia, the United Arab Emirates, and South Africa, during the last few years, and the market for Lidocaine is likely to develop in the area.

Market Restraining Factors

  • Lack of Skilled anesthesiologists: The majority of patients undergoing surgery in many poor countries, particularly in rural regions, are emergency cases. The problem is that there is a scarcity of competent anaesthesiologists in many developing nations, which is a serious obstacle that could stymie the expansion of the Lidocaine market in many developing countries, particularly in Africa.

Key Market Opportunities

  • Increase in Cosmetic Procedures: Surgical cosmetic surgeries are in high demand all around the world, particularly in countries such as South Africa, UAE, Saudi Arabia, Israel. However, the popularity of specific aesthetic procedures varies by country’s geographical location. Surgical and non-surgical cosmetic procedures are growing in popularity in LAMEA, with no indications of slowing down, driving up demand for Lidocaine.

Regional Analysis

The LAMEA Lidocaine Market is predicted to reach USD 96.28 million by 2030, growing at a 5.15% CAGR during the forecast period (2022–2030), and the Middle East and Africa Lidocaine Market is likely to reach USD 96.28 million by 2030. Lidocaine Market size is estimated to reach USD 273.77 million by 2030, with a 5.30% compound annual growth rate (CAGR) over the forecast period (2022–2030). The usage of lidocaine as an anti-itch and pain relief for bug bites, minor wounds, burns, skin scrapes, and eczema has boosted demand and propelled the industry forward. The effect factors in Latin America are favourable to the region's development. Over the last few years, the number of procedures performed around the world, particularly in parts of the Middle East and Africa, has risen rapidly. The growing demand for postoperative pain treatment options following an increasing number of surgeries is a crucial development. The market for lidocaine ointment is expected to benefit from this trend. The demand for lidocaine ointment is expected to increase as a result of this trend.

The Middle East and Africa region's lidocaine market is dominated by the United Arab Emirates. The market in the UAE is being driven by an increase in the number of dental and plastic surgery procedures performed, as well as the availability of various products in the region. Liposuction is the most desirable cosmetic surgery for ladies in the UAE right now. As a result, healthcare spending has climbed, as has the number of individuals who require post-surgical pain relief ointment.

During the forecast period, the Saudi Arabia lidocaine market is expected to develop at the fastest rate. This increase can be attributed to an increase in the number of dental and cosmetic surgeries performed, advances in surgical procedures, and increased awareness of cosmetic and plastic surgery possibilities.

Brazil is predicted to have a moderate share in Latin American markets during the figure time frame, owing to an increase in the number of rich patients, medical operations, and higher lidocaine appropriation infusions as neighbourhood sedatives during medical procedures.

Countries like Mexico and Argentina are becoming more interested in lidocaine definitions, medical care usage, and the ageing patient population, all of which are creating market development potential in Latin America.

Report Scope

Report Metric Details
By formulation
  1. Injections
  2. Creams
  3. Ointments
  4. Gel
By Application
  1. Dentistry
  2. Cardiac Arrhythmia
  3. Epilepsy
  4. Cosmetic Surgery
  5. General Surgery
By Distribution Channel
  1. Hospitals Outlets
  2. Retail Pharmacies
Company Profiles Fujifilm Holdings Corporation Glenmark Pharmaceutical Limited Pfizer, Inc AstraZeneca Plc. Glenmark Pharmaceuticals Novocol Inc. and Centura Pharmaceuticals
Geographies Covered
LAMEA Brazil Mexico Argentina Chile Colombia UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of LAMEA
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

According to the formulation, the section is divided into injections, creams, ointments, gels, and others. Lidocaine hydrochloride is available in a number of different forms, including a 2% viscous solution, a 2% gel, a 4% solution, and a 10% topical spray. Lidocaine base is available in 5%, 2.5%, and 10% concentrations in solutions and ointments, as well as a 10% aerosol spray. Furthermore, the ointments category is likely to grow at the quickest rate during the forecast period. This is due to the growing use of lidocaine ointments as cosmetic surgery products.

Depending on the application, the section is divided into dental, cardiac arrhythmia, epilepsy, aesthetic surgery, general surgery, and others. The dentistry industry is predicted to have the greatest market share in 2020. The demand for injectable lidocaine hydrochloride solutions in dental surgical procedures is driving its dominance. This, together with a rise in the number of dental problems and chronic and acute pain associated with dental operations, is expected to move the market ahead. Oral problems will affect about 3.5 billion individuals by 2020, according to the World Health Organization.

Based on distribution channels, the market is divided into hospital outlets, retail pharmacies, and others. The hospital outlets segment will account for the majority of the lidocaine market in the region by 2020. This is mostly due to better infrastructure and facilities, as well as a growth in the incidence of dental, aesthetic, and general operations, higher awareness of illness diagnosis and treatment, and an increase in the number of patients globally.

During the assessment period, market expansion will be aided by the establishment of hospital pharmacies in cardiology, neurology, and other illnesses in both developed and developing countries, as well as an increase in the number of hospitals and appropriate reimbursement scenarios.

Market Size By formulation

Top Key Players

Fujifilm Holdings Corporation Glenmark Pharmaceutical Limited Pfizer, Inc AstraZeneca Plc. Glenmark Pharmaceuticals Novocol Inc. and Centura Pharmaceuticals Others

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the LAMEA Lidocaine Market?
The LAMEA Lidocaine Market size is growing at a CAGR of 5.15% from 2017 to 2029.
Rising dental health demand will boost the lidocaine market,increasing chronic pain-related disorders are the key driver for the growth of the market.
The key players in the global Market include Fujifilm Holdings Corporation , Glenmark Pharmaceutical Limited , Pfizer, Inc , AstraZeneca Plc. , Glenmark Pharmaceuticals.

We are featured on :